domingo, 10 de septiembre de 2023

Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society from the Journal Breast Cancer Research

https://www.springernature.com/gp/researchers/campaigns/highlights/oncology-hematology?utm_medium=banner&utm_source=bmc&utm_content=skyscraper&utm_term=null&utm_campaign=MLSR_ALLPR_BAWG_GL_PMLS_005NK_ONCOL

No hay comentarios:

Publicar un comentario